The abundance of erythroid progenitors in haematopoietic tissue provides a unique opportunity to dissect how multipotent progenitors (MPPs) differentiate into a single lineage in situ, a process of fundamental biological interest and of clinical relevance. Erythropoiesis has two principal phases: erythroid terminal differentiation (ETD), in which GATA1-driven transcription remodels erythroid precursors into red blood cells through several well-described stages 1-3 ; and an earlier, lesswell-delineated phase of early erythropoiesis, in which haematopoietic stem cells (HSCs) differentiate through poorly defined intermediates into erythroid progenitors. Erythroid progenitors have been identified by their colony-forming potential in semi-solid medium, as either burst-forming (BFU-e) or colony-forming (CFU-e) progenitors 4,5 . A direct, complete and high-purity isolation of adult mouse BFU-e and CFU-e from haematopoietic tissue has not, to our knowledge, been attained 6-9 . More broadly, there are no known strategies that systematically identify the entire cellular and molecular trajectory of the early erythroid lineage as it first arises from the HSC compartment and progresses to the point at which ETD is activated.
The abundance of erythroid progenitors in haematopoietic tissue provides a unique opportunity to dissect how multipotent progenitors (MPPs) differentiate into a single lineage in situ, a process of fundamental biological interest and of clinical relevance. Erythropoiesis has two principal phases: erythroid terminal differentiation (ETD), in which GATA1-driven transcription remodels erythroid precursors into red blood cells through several well-described stages [1] [2] [3] ; and an earlier, lesswell-delineated phase of early erythropoiesis, in which haematopoietic stem cells (HSCs) differentiate through poorly defined intermediates into erythroid progenitors. Erythroid progenitors have been identified by their colony-forming potential in semi-solid medium, as either burst-forming (BFU-e) or colony-forming (CFU-e) progenitors 4, 5 . A direct, complete and high-purity isolation of adult mouse BFU-e and CFU-e from haematopoietic tissue has not, to our knowledge, been attained [6] [7] [8] [9] . More broadly, there are no known strategies that systematically identify the entire cellular and molecular trajectory of the early erythroid lineage as it first arises from the HSC compartment and progresses to the point at which ETD is activated.
Probing the earliest stages of erythropoiesis requires exploring how MPPs diversify into progenitors for each of the haematopoietic lineages. Single-cell approaches have recently challenged established models of haematopoiesis, showing that progenitor populations that were thought to be similar in their developmental stage and fate potentials are in fact highly heterogeneous in both respects [10] [11] [12] [13] [14] [15] [16] [17] . Alternative models replaced the classic haematopoietic tree [18] [19] [20] with a 'flatter' hierarchy, in which unilineage progenitors derive directly from a heterogeneous set of lineage-biased multipotent progenitors. These new models are highly dependent on the tools used in the analysis of high-dimensional cell transcriptional states, which are currently undergoing intense innovation [21] [22] [23] [24] [25] [26] . Descriptions of the haematopoietic hierarchy structure have so far relied on clustering 12 , which may fail to capture continuums; diffusion maps 26, 27 , which are powerful for branching models but provide less detail of highly complex processes; and the ordering of progenitors on the basis of their similarity to differentiated cell types 16 , which may overlook progenitors that do not resemble mature cells. Fluorescenceactivated cell sorting (FACS) may also introduce bias into reconstructed developmental trajectories, through overly restrictive gates 15 and the loss of sensitive cells 28 . It is still not clear how to reconcile cell fate assays with the cell-state maps proposed from the results of single-cell profiling, and this remains a general challenge in stem-cell biology.
Here we investigated the derivation and subsequent development of erythroid progenitors by undertaking single-cell RNA sequencing (scRNA-seq) of a broad set of haematopoietic progenitors, using the inDrops platform 29 . We developed an analytical tool, population balance analysis (PBA), which can be used to predict cell fate probabilities from static snapshots of single-cell transcriptomes through dynamic inference. PBA allowed us to define a FACS strategy to isolate cells in progressive stages of early erythropoiesis. Using single-cell fate assays, we then confirmed a number of detailed predictions regarding the early haematopoietic hierarchy and erythroid developmental progression. The insights obtained into early erythropoietic fate control may be applicable to other differentiation models, and include novel erythropoietic regulators with potential therapeutic relevance.
scRNA-seq of Kit + progenitors
We performed scRNA-seq on Kit + haematopoietic progenitor cells (HPCs) isolated using magnetic beads from the bone marrow of adult mice (Fig. 1a ). Kit is expressed on all haematopoietic stem and early progenitor cells 30, 31 , enabling an inclusive approach that preserves the relative abundance of progenitor cell states. After filtering, we carried forward 4,763 HPC transcriptomes for analysis (see 'Data availability' in Methods for interactive tools).
We visualized the scRNA-seq data using the SPRING algorithm 32 (Fig. 1b) , which generates a graph of cells (graph nodes) connected to their nearest neighbours in gene expression space and projected into two dimensions using a force-directed graph layout. This visualization The formation of red blood cells begins with the differentiation of multipotent haematopoietic progenitors. Reconstructing the steps of this differentiation represents a general challenge in stem-cell biology. Here we used single-cell transcriptomics, fate assays and a theory that allows the prediction of cell fates from population snapshots to demonstrate that mouse haematopoietic progenitors differentiate through a continuous, hierarchical structure into seven blood lineages. We uncovered coupling between the erythroid and the basophil or mast cell fates, a global haematopoietic response to erythroid stress and novel growth factor receptors that regulate erythropoiesis. We defined a flow cytometry sorting strategy to purify early stages of erythroid differentiation, completely isolating classically defined burst-forming and colony-forming progenitors. We also found that the cell cycle is progressively remodelled during erythroid development and during a sharp transcriptional switch that ends the colony-forming progenitor stage and activates terminal differentiation. Our work showcases the utility of linking transcriptomic data to predictive fate models, and provides insights into lineage development in vivo.
suggested that HPCs occupy a continuum of transcriptional states, rather than discrete metastable states, a result that contrasts with single-cell data from mature blood lineages and is supported by formal tests of graph interconnectivity (Extended Data Fig. 1a ). When SPRING plots were coloured on the basis of the expression of lineage-specific markers ( Fig. 1b, Supplementary Table 1 ), the cells were found to organize around an undifferentiated core, from which seven distinct branches emerge, corresponding to progenitors of the basophil or mast cell (Ba/Mast), granulocytic neutrophil, monocytic, dendritic, lymphoid, megakaryocytic and erythroid lineages. Although this structure depends critically on collecting cells using a broad selection marker, SPRING visualization of data from previous studies 12, 15 revealed the same lineage relationships (Extended Data Fig. 1b ).
PBA of the HPC continuum
To understand the differentiation trajectories that cells might follow, we developed the PBA 33 approach for studying single-cell continua (Extended Data Fig. 1c, d) . PBA maps each cell to a low-dimensional space that encodes the cell-graph topology in the form of predicted cell fate probabilities. The derivation and limitations of PBA have been detailed elsewhere 33 . The core of PBA can be understood as the reconstruction of the memoryless stochastic dynamics of cells, which, through ongoing cell turnover, explains the observed steady-state distribution of cell states. PBA approximates the dynamics of cells as following the gradient of a potential landscape, which itself can be inferred through an asymptotic relationship between diffusiondrift processes and the spectral properties of the SPRING graph 33 .
The probabilities obtained by PBA represent formal biophysical predictions for the fate of cells under simplified assumptions, but they can also be treated heuristically as encoding graph distances. Applied to our data, PBA defines seven putative commitment probabilities for each haematopoietic progenitor ( Fig. 1c , Extended Data Fig. 1e ), as well as the distance from the undifferentiated CD34 high Sca1 high MPPs (Fig. 1d ).
The transcriptional continuum of HPCs is hierarchical
We used PBA-predicted commitment probabilities to compute a coupling score that reflects whether any two fate potentials occur concurrently in single progenitors at higher rates than would be expected by chance (Fig. 1e) . A transcriptional-state hierarchy was formalized by identifying correlated pairs of terminal fates and joining them iteratively until a multipotent state was reached ( Fig. 1e, f) . The resulting topology firmly supports the hierarchical view of haematopoiesis, with MPPs diverging into progenitors with either correlated erythroid, Ba/Mast and megakaryocytic fates, or with correlated lymphoid and myeloid fates (Fig. 1f ). However, the transcriptional-state hierarchy emerges from correlations on a continuum, rather than from discrete populations. Additionally, it predicts two refinements over current models. First, the erythroid fate is correlated with the Ba/Mast fates. Second, among myeloid progenitors we identified dendriticmonocyte and granulocytic-monocyte coupling, but no dendriticgranulocytic coupling, suggesting that monocyte differentiation may occur through two distinct trajectories, a prediction that was very recently independently confirmed 34 . The PBA-formalized HPC hierarchy also allowed us to identify genes for which expression closely correlates with each cell fate choice (Extended Data Fig. 2 , Supplementary Table 2 ).
Isolation of putative erythroid progenitors
To test PBA predictions ( Fig. 1e-f ), we developed a FACS strategy that isolates haematopoietic subpopulations defined by scRNA-seq. Guided by the single-cell expression patterns, we combined Kit expression with CD55, a marker of megakaryocytic and erythroid bias 10 ; Kit + CD55 + cells were divided into subpopulations (P1-P5), using CD49f (encoded by Itga6) and megakaryocytic and erythroid markers 6, 9, 10 ( Fig. 2a ). Using reverse transcription with quantitative PCR (qRT-PCR) (Extended Data Fig. 3a ), and scRNA-seq (11,241 cells postfilter) ( Fig. 2b , Extended Data Fig. 3b -e), we mapped cells from each of the sorted subpopulations back to regions of the SPRING graph. We found that P1 and P2 represent high-purity subpopulations on the putative erythroid branch, with P1 predicted to be committed, and P2 mostly committed, to the erythroid fate ( Fig. 1c ). P3 and P4 are enriched for the Ba/Mast and megakaryocytic branches, respectively; P3 bifurcates into separate basophil and mast cell branches. P5 contains erythroid-biased oligopotent and multipotent cells. Myeloid, lymphoid and some MPP states are within the CD55 − region of the plot.
Functional identification of correlated cell fates
We next examined the differentiation potential of the sorted P1-P5 populations, and by extension, the predicted fate probabilities for their corresponding transcriptional states. Colony-forming assays showed that P1 and P2 contain all of the unipotential erythroid progenitors and no other progenitors ( Fig. 2c-e ). P1 colonies were small and unifocal, maturing on day 3 or later (CFU-e) ( Fig. 2c ), whereas P2 colonies were largely multifocal, maturing on day 4 or later (BFU-e) ( Fig. 2d ). Thus, P1 is closer to erythroid maturation than P2, consistent with PBA predictions (Figs 1c, 2b) . Furthermore, the transcriptional state of progenitors as defined by the SPRING map determines their ability to form either multifocal or unifocal colonies. Consistent with the SPRING plot, the less-differentiated P5 population gave rise to mixed myeloid colonies, and P4 was enriched for megakaryocytic progenitors ( Fig. 2e , Extended Data Fig. 4a ). 
PBA-predicted
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To test HPC fate potential further, we sorted single Kit + cells into liquid culture wells in the presence of cytokines that support myeloid and erythroid differentiation ( Fig. 3a) . We assayed the clonal output of 1,158 single cells by FACS ( Fig. 3b , Extended Data Fig. 4b ). Unipotential clones for the erythroid, Ba/Mast, megakaryocytic, and granulocytic neutrophil and monocytic (GN/M) lineages largely originated in the P1/P2, P3, P4 and CD55 − subpopulations, respectively, consistent with predictions (Figs 1c, 2b, 3b). Many clones contained multiple lineages, with strong, statistically significant couplings between the erythroid, Ba/Mast and megakaryocytic cell fates on the one hand, and the GN/M fates on the other ( Fig. 3c ; absolute z-score value of more than 10 when compared to randomized data), consistent with both known (erythroid and megakaryocytic, GN/M) and novel (erythroid and Ba/Mast) PBA predictions ( Fig. 1c , e, f). Progenitors with erythroid and Ba/Mast output were enriched in the P2 and P5 subpopulations ( Fig. 3d ), which map close to the erythroid and Ba/Mast branch point in the scRNA-seq data (Figs 1c, 2b), and were depleted in the CD55 − population, as predicted. We found similar results in bulk liquid cultures (Extended Data Fig. 4c ). Notably, the new Ba/Mast differentiation pathway suggested by our data does not rule out Ba/Mast formation by the traditional route, as some clones gave rise to both granulocytic neutrophil and Ba/Mast lineages. These results suggest that erythroid, Ba/Mast and megakaryocytic fates are coupled transcriptionally and functionally, while being anti-coupled to the GN/M fates, and that scRNA-seq data can be used to generate successful predictions of HPC states and fates.
The erythroid differentiation trajectory
Integrating the cell fate assays and scRNA-seq analysis, we partitioned the continuum of cell states between MPPs and ETD into three stages ( Fig. 4a ): (1) erythroid-basophil-megakaryocyte-biased progenitors (EBMPs), (2) early erythroid progenitors (EEPs) and (3) committed erythroid progenitors (CEPs). EBMPs are oligopotent cells near the branch points of the megakaryocytic and basophil lineages, which are biased away from the GN/M fates and strongly represented in the P5 and P2 subpopulations ( Fig. 2b ). EEPs occupy a narrow region of the graph, just past the final non-erythroid fate branch point; they form most of the P2 subpopulation and are functionally BFU-e ( Fig. 2b-d) . CEPs constitute the majority of unipotential erythroid progenitors, form most of the P1 subpopulation, and are functionally CFU-e ( Fig. 2b-d) .
To establish the transcriptional events of the erythroid trajectory, we created a smoothed time series for every gene from MPP to ETD, akin to published pseudotemporal-ordering algorithms [35] [36] [37] (Fig. 4b ).
Known erythroid regulators recapitulated the expected expression dynamics ( Fig. 4c ). Gata1 and the erythropoietin (EPO) receptor, Epor, were induced early, concurrent with suppression of Spi1 (which encodes PU.1) and Gata2 (ref. 38). The transition to ETD was marked by a sharp induction of erythroid genes such as α-globin (Hba-a1). We validated the expression of canonical transcription factors in sorted P1-P5 subpopulations, including the early expression of Gata1 (Extended Data Fig. 5a, b ). We further established that a graded increase in Tfrc (which encodes CD71) is a reliable marker of continuous progression through the EEP and CEP stages; transcriptomes of sorted CD71 high P1 cells map to late CEP stage and CD71 gradually increases in sorted P2 and P1 cells differentiating in vitro (Extended Data Fig. 5c, d ). 
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A further, sharp induction of Tfrc takes place at the transition to ETD ( Fig. 4c ).
Of the approximately 4,500 genes that varied significantly along the erythroid trajectory ( Supplementary Table 3 ), a large group was induced at the onset of the CEP stage, and sharply suppressed at the CEP to ETD transition ( Fig. 4b ). It contained the most dominant dynamic gene clusters and was enriched for cell cycle and growthrelated genes, including those involved in mTOR signalling, nucleotide metabolism and DNA replication (Extended Data Figs 5e, 6a, b, Supplementary Table 4 ). These pathways suggest that CEPs, which are the most abundant cells in early erythropoiesis, act as an 'amplification' module. Our analysis predicts new epigenetic and transcriptional regulators of the erythroid lineage (Extended Data Fig. 6 , Supplementary  Table 4 ), and shows that although GATA1 is expressed early in the erythroid trajectory, most of its canonical targets are induced only at the transition to ETD. Taken together, the temporal ordering of the single-cell transcriptomes recapitulates known events of early erythropoiesis and uncovers a dedicated CEP transcriptional program that is distinct from the ETD program.
Erythroid stress generates a broad response
Using scRNA-seq, we examined two model systems of accelerated, or stress, erythropoiesis: the mid-gestation fetal liver (n = 7,182 cells post-filter), in which erythropoiesis is a rate-limiting factor of fetal growth; and bone marrow from mice treated with EPO for 48 h, stimulating red blood cell production (n = 2,611 cells post-filter). SPRING graphs revealed a remarkable conservation of the key features of the haematopoietic hierarchy and erythroid differentiation during stress (Fig. 4d ). The proportion of erythroid-trajectory cells increased with stress ( Fig. 4d, e ). In the fetal liver, the increase was predominantly in CEPs, whereas in EPO-stimulated bone marrow, all erythroid-trajectory cells increased in abundance, including uncommitted MPPs and EBMPs. We found that the absolute number of Kit + cells in EPOstimulated bone marrow did not change, indicating that the increase in erythroid-trajectory cells came at the expense of other cell lineages ( Fig. 4e , Extended Data Fig. 7 ). A number of mechanisms could account for this, including altered intrinsic fate bias of MPPs 39,40 .
EPO addition altered gene expression principally in EEPs and CEPs, but also in EBMPs and MPPs ( Fig. 4f ), in which targets of The SPRING plot shows PBA-predicted erythroid fate probability. b, Top, dynamically varying genes (rows), ordered by peak expression, in cells (columns) ordered from MPP to ETD. Gene expression data were smoothed using a Gaussian kernel. Bottom, the number of genes turning on or off (density of expression inflection points) throughout the progression from MPP to ETD. The x axis represents PBA-predicted differentiation ordering of cell transcriptomes, uniformly spaced from the least (0%) to the most (100%) differentiated. c, Gene expression traces for established erythroid genes. d, SPRING plots of EPO-stimulated bone marrow (eBM) and fetal liver samples. Cells coloured as in Fig. 1b . e, Left, erythroid lineage expansion at the expense of non-erythroid cells (see Extended Data Fig. 7 ). Among uncommitted cells, erythroid-biased progenitors increased, whereas the remainder diminished. Committed cells were defined by a PBA-predicted erythroid fate probability greater than 0.5. Right, change in abundance of each progenitor stage relative to basal bone marrow. Error bars are the sampling s.e.m. (one sample per condition). f, EPO-stimulated differential gene expression. Cells from EPO-stimulated bone marrow were first mapped onto the basal bone marrow SPRING plot, and then differentially expressed (DE) genes were analysed. g, Summary of the stress erythropoiesis response.
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CCAAT-enhancer-binding protein β (C/EBPβ), a transcription factor that biases differentiation away from erythroid and megakaryocytic fates 41 , were downregulated. We identified both known 42,43 and new stress-responsive genes, together with their precise localization within the erythroid trajectory (Extended Data Fig. 8 , Supplementary  Table 5 ).
Taken together, we found that the cell-state branching structure is maintained during accelerated erythropoiesis. In MPPs and throughout the ensuing erythroid progression, we identified changes in gene expression and in cell abundance in response to EPO well beyond the currently known mechanism of EPO-driven erythropoietic expansion 42,44 .
Growth factor regulators of early erythropoiesis
We screened EEPs and CEPs for gene expression of cell-surface receptors with known ligands using qRT-PCR, identifying three such receptors encoded by Ryk, Mst1r and Il17ra (Fig. 5a , Extended Data Fig. 9a, b ). RYK and MST1R have previously been reported in CFU-e, but their function remains unknown 45, 46 . However, the expression of an IL-17A receptor by EEPs has not, to our knowledge, been documented. We stimulated RYK, MST1R and IL-17RA with their respective ligands, WNT5A, macrophage-stimulating protein (MSP) and IL-17A, using erythroid colony formation as a readout (Fig. 5b , Extended Data Fig. 9c ). In the fetal liver sample, in the presence of low levels of EPO (50 mU ml −1 ), MSP doubled the number of CFU-e colonies, equivalent to a tenfold increase in EPO concentration. MSP was inhibitory in other contexts, and WNT5A was a potent inhibitor of erythroid colony formation in both the fetal liver and bone marrow samples. By contrast, IL-17A mediated a marked potentiation of adult bone marrow CFU-e colony formation, quadrupling colonies at low levels of EPO (50 mU ml −1 ), and increasing them by approximately 50% at high levels of EPO (500 mU ml −1 ).
The stimulatory effect of IL-17A required endogenous IL-17RA ( Fig. 5c ) and was also evident in human bone marrow ( Fig. 5d ). Furthermore, IL-17A stimulation was saturable, with a low halfmaximum effective concentration (EC 50 ) (60 pM), consistent with high-affinity binding of IL-17A to IL-17RA. IL-17A induced rapid phosphorylation of the intracellular signalling mediators STAT3 and STAT5 in CEPs and EEPs (Fig. 5e ), and western blotting of freshly sorted CEP P1 and EEP P2 cells revealed expression of IL-17RA (Extended Data Fig. 9d ). Taken together, our findings suggest previously unknown regulation of EEPs and CEPs through the expression of a number of growth factor receptors.
Cell cycle remodelling during erythroid development
In a final analysis, we asked what governs progression through the CEP stage and its termination during ETD. We previously reported that the onset of ETD in the fetal liver occurs within a single S phase, and is dependent on S-phase progression 47 ; furthermore, this unique S phase is shorter and faster than the S phase in pre-ETD cells 48,49 . These conclusions, which are based on the analysis of large fetal liver subpopulations, predict that CEP exit should show an S phase signature. In our scRNA-seq data, we found that the expression levels of genes that mark the G1/S, S, G2 and G2/M cell cycle phases form a sequence of close, sharp peaks during CEP exit, probably representing a single cell cycle ( Fig. 6a, b ). This and the following results hold even when cell cycle genes are omitted for ordering the erythroid trajectory (Extended Data Fig. 10a-c) . Notably, by reversibly inhibiting DNA replication, we found that the CEP-to-ETD transition in adult bone marrow not only synchronized with, but also depended on, S phase progression (Extended Data Fig. 10d-f ).
The scRNA-seq data revealed that changes to cell cycle machinery occur throughout the CEP stage, perhaps in preparation for the switch to ETD. Genes with expression levels that most closely correlate with CEP progression (Supplementary Table 6 ) are enriched for Gene Ontology terms associated with DNA replication. Notably, regulators of S phase and the G1/S-phase transition increase steadily through the CEP stage, including cyclin E1 (encoded by Ccne1), cyclin A2 (Ccna2) and MCM helicase subunits (Mcm2-Mcm7). Conversely, regulators of the G1 phase such as cyclin D2 (Ccnd2) and cyclin-dependent kinase 6 (Cdk6) decrease steadily ( Fig. 6c ). To investigate these findings, we labelled S-phase cells in vivo with the nucleotide analogue BrdU, and analysed the cell cycle distribution of cells as they progressed through the EEP and CEP stages ( Fig. 6d-f ). We found a graded but notable increase in the fraction of cells in S phase, whereas the number of G1 cells correspondingly decreased. Results were similar in both EPO-stimulated bone marrow and fetal liver samples (Extended Data Fig. 10g ). There was no significant change in the length or speed of S phases, as evidenced by stable intra-S-phase levels of BrdU 48 ( Fig. 6f ), suggesting that cells spend more time in S phase as a result of G1 shortening. Western blotting of sorted P1 and P2 fractions confirmed that the expression of key S-phase regulators increased with developmental progression in EEPs and CEPs (Extended Data Fig. 10h ). Taken together, our data suggest that progression through the erythroid trajectory is associated with extensive remodelling of the cell cycle ( Fig. 6g ).
Discussion
Our scRNA-seq analysis reveals that HPCs occupy a continuum of transcriptional cell states, branching towards seven fates. Certain cell fate potentials are correlated, supporting a hierarchical view of haematopoiesis, with MPPs diverging either towards myeloid and Article reSeArcH lymphoid fates, or towards the erythroid, megakaryocyte and Ba/Mast cell fates. Yet unlike the classical models of haematopoiesis, HPCs do not separate into discrete and homogenous stages. The coupling of specific cell fates, which we validated with single-cell fate assays, is a critical feature by which our model differs from recent models of haematopoiesis, in which unilineage progenitors arise directly from MPPs. Our model also explains historical hierarchical interpretations of haematopoiesis, which were based on fate assays of FACSgated populations, averaging the fate couplings of their constituent progenitors. Of note, the continuous nature of the scRNA-seq data does not rule out the existence of discrete epigenetic or signalling states among HPCs, if their lifetime in single cells is comparable to, or shorter than, the lifetime of mRNA molecules (in the range of hours to approximately 1 day).
We delineated the continuous differentiation trajectory of the erythroid lineage, from its origins in MPPs, through EBMPs, to unipotential EEPs and CEPs, which we show correspond to the unipotential BFU-e and CFU-e, respectively. The dominant CEP stage expresses a distinct transcriptional program and is probably a regulator of erythroid output, as evidenced by both its expansion under stress, and by novel growth factor receptors that regulate CFU-e numbers. In particular, our finding of strong stimulation by the pro-inflammatory IL-17RA contributes to the growing evidence of a complex interplay between erythropoiesis and inflammation 50, 51 . We further identified the cell cycle as a key process in both the progression and termination of the CEP stage. Developing CEPs spend an increasing fraction of their time in S phase, as a result of G1 shortening; their transition to ETD in an abrupt transcriptional switch is dependent on a single, short S phase. We speculate that the cell cycle may set the context for activation of transcription factors that are induced earlier in the erythroid trajectory. Taken together, our single-cell approach allowed us to make detailed predictions that we validated to reveal novel fundamentals of early haematopoietic differentiation, as well as practical methods for further isolation and study of these cells.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Cell colouring represents consecutive 7-percentile gates of increasing CD71, reflecting progression through the EEP (P2) and CEP (P1) stages (Extended Data Fig. 5c, d) . The transition to ETD (red arrow) is marked by a sharp increase in CD71, and synchronization in the S phase (BrdU + ). 
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MethOdS
No statistical methods were used to predetermine sample size, the experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Single-cell transcriptome droplet microfluidic barcoding using inDrops. For scRNA-seq, we used inDrops 29 following a previously described protocol 53 with the modifications summarized in Supplementary Table 7 . Following droplet barcoding reverse transcription, emulsions were split into aliquots of approximately 1,000 single-cell transcriptomes and frozen at −80 °C. Two batches of Kit + libraries were prepared, referred to as batch 1 (bBM, n = 840 cells; eBM, n = 1,141 cells; FL, n = 1,953 cells) and batch 2 (bBM, n = 4,592 cells; eBM, n = 1,314 cells; FL, n = 7,529 cells) in Supplementary Table 7 . These cell numbers correspond to the final number of transcriptomes detected upon sequencing (see 'Cell filtering and data normalization'), and were in agreement with estimated inputs. For the FACS subsets P1, P1-CD71 high , P2, P3, P4, and P5 (referred to collectively as 'P1-P5'), all libraries were prepared in parallel, with a total of 16,206 cell barcodes detected in the sequencing data before filtering (P1, n = 5,733 cells; P1-CD71 high , n = 1,631 cells; P2, n = 2,630 cells; P3, n = 2,101 cells; P4, n = 1,589 cells; P5, n = 2,522 cells). Sequencing and read mapping. The first batch of Kit + (bBM, eBM and FL) libraries was sequenced on a HiSeq 2000, the remaining Kit + libraries were sequenced on three NextSeq 500 runs, and all P1-P5 libraries were sequenced on a single NextSeq 500 run. Raw sequencing data (FASTQ files) were processed using the previously described 53 inDrops.py bioinformatics pipeline (available at https:// github.com/indrops/indrops), with a few modifications. Bowtie v.1.1.1 was used with parameter -e 100; all ambiguously mapped reads were excluded from analysis and reads were aligned to the Ensemble release 81 mouse mm10 cDNA reference. Cell filtering and data normalization. Each sample (bBM, eBM, FL and P1-P5) was processed separately. The bBM, eBM and FL samples (referred to collectively as Kit + ) were initially filtered to include only abundant barcodes, on the basis of visual inspection of the histograms of total reads per cell (see cell numbers reported in 'Single-cell transcriptome droplet microfluidic barcoding using inDrops'). An additional filtering step removed cells with transcript count totals in the bottom fifth percentile (bBM, n = 271 cells; eBM, n = 148; FL, n = 473). Subsets P1-P5 were filtered only by total transcript counts, with thresholds set by visual inspection of the total counts histograms (see cell numbers reported in 'Single-cell transcriptome droplet microfluidic barcoding using inDrops'). Next, we excluded putatively stressed or dying cells with >10% (bBM, eBM and FL) or >20% (P1-P5) of their transcripts coming from mitochondrial genes (bBM, n = 165 cells; eBM, n = 45; FL, n = 698; P1, n = 2,629; P1-CD71 high , n = 879; P2, n = 195; P3, n = 69; P4, n = 379; P5, n = 62).
After cell filtering, we detected the following median number of transcripts and genes per cell, respectively: bBM, 2,989 and 1,539; eBM, 3, 082 and 1,552; FL, 8,859  and 2,834; P8, 3,339 and 1,637; P8-CD71 high , 4,740 and 2,174; P9, 2,712 and 1,393;  P10, 4,641 and 2,158; P11, 1,783 and 1,023; P12, 2,139 and 1 ,195. The gene expression counts of each cell were then normalized using a variant of total-count normalization that avoids distortion from very highly expressed genes. Specifically, we calculated x i j , , the normalized transcript counts for gene j in cell i, from the raw counts x i,j as follows:
and X is the average of X i over all cells. To prevent very highly expressed genes (for example, haemoglobin) from correspondingly decreasing the relative expression of other genes, we excluded genes comprising >10% of the total counts of any cell when calculating X and X i . Exclusion of contaminating cell types and putative cell doublets. To clean up the data for the Kit + samples, we clustered the single-cell transcriptomes and excluded clusters that were identified as contaminating (non-HPC) cell types and putative cell doublets. No such clusters were detected in the P1-P5 samples. Clustering was performed as follows: we identified the principal variable genes across the entire dataset, as described 29 , that is, genes that were highly variable (top 2,000 most variable by v-score, a measure of above-Poisson noise (variability)), expressed at non-negligible levels (at least five unique molecular identifier (UMI)-filtered mapped reads (UMIFM) in at least three cells), and which contributed to principal components with eigenvalues greater than those obtained after data randomization (n = 59, n = 35 and n = 71 principal components for bBM, eBM and FL samples, respectively). The expression level for each gene was standardized by a z-score transform (mean-subtraction, scaling by s.d.), followed by density-based clustering (DBSCAN) 54,55 on a 2D PCA-tSNE plot (principal component analysis (PCA) followed by t-distributed stochastic neighbour embedding (tSNE 56 ), as described 29,57 ). The tSNE algorithm perplexity parameter was set to 30. Examination of the expression of marker genes in each cluster was then used to identify putative doublets and contaminating cell types.
In the bBM sample, two doublet clusters were identified: one co-expressed markers of mature macrophages and erythrocytes (n = 38 cells), and the other co-expressed markers of granulocyte and erythroid progenitors (n = 75 cells). The eBM sample included a cluster of mature macrophages (n = 40 cells) but no identifiable cluster of doublets. The FL sample contained four contaminating cell types: vascular endothelium, hepatocytes, mesenchymal cells and mature macrophages (n = 769 cells total), in addition to a small cluster of doublets (n = 18 cells). Doublets and contaminant cells were excluded from downstream analyses.
To increase confidence that putative doublet clusters were indeed combinations of two single cells, rather than true intermediate or transitional states, we generated simulated 'artificial' doublets by randomly sampling and combining observed transcriptomes.
We then applied PCA-tSNE clustering as described earlier to the union of observed and simulated cells, and identified clusters that were primarily composed of cells with a large number of doublet neighbours (two clusters in bBM, one in FL). These clusters were the same putative doublet clusters identified in the previous paragraph. Batch correction. Within each Kit + sample, we observed batch effects between the first and second sequencing runs, with slightly fewer genes detected per cell in the second run compared to the first run. This was consistent with the choice of lower sequencing depth used in the second set of runs, but could also reflect differences in library preparation despite all cells being collected in a single droplet run. To prevent batch effects from distorting subsequent data analysis, for each sample we used the second (larger) batch to select variable genes and to calculate principal component gene loadings. Cells from all batches were then projected into the reduced space, and all subsequent analysis was performed on the reduced principal component space.
Data visualization and construction of k-nearest neighbour graphs.
After cell filtering, data were prepared for visualization and PBA 33 by constructing a k-nearest neighbour (kNN) graph, in which cells correspond to graph nodes and edges connect cells to their nearest neighbours. A kNN graph was constructed separately for each of the three Kit + samples and for the merged P1-P5 samples (note that the kNN graph for P1-P5 was used only for the visualization in Extended Data Fig. 3 ).
For the Kit + samples, genes with mean expression > 0.05 and coefficient of variation (s.d./mean) > 2 were used to perform PCA down to 60 dimensions (bBM, eBM and FL). For all analyses in this paper, data were z-score normalized at the gene level before PCA (qualitatively similar results were also obtained without z-score normalization, which weights highly expressed genes more heavily than lowly expressed genes). After PCA, a kNN graph (k = 5) was constructed by Article reSeArcH connecting each cell to its five nearest neighbours (using Euclidean distance in the principal component space).
For P1-P5, highly variable genes were filtered using the v-score statistic (above-Poisson noise) rather than the coefficient of variation, keeping the top 25% most variable genes and requiring at least three UMIFM to be detected in at least three cells (n = 3,459 genes). Additionally, a strong cell cycle signature was observed in the initial graph visualization, manifested by the co-localization of cells expressing G2/M genes (Ube2c, Hmgb2, Hmgn2, Tuba1b, Mki67, Ccnb1, Top2a, Tubb4b). Therefore, we constructed a G2/M signature score by summing the average z-score of these genes, then removed genes that were highly correlated (Pearson r > 0.2) with the signature (n = 31 genes). Finally, the kNN graph was constructed with k = 4 using the first 30 principal components.
The kNN graphs were visualized using a force-directed layout using a custom interactive software interface called SPRING 58 . For the Kit + samples, several manual steps were taken to improve visualization. It is important to emphasize that the manipulations affect visualization only. All subsequent analyses depend on the graph adjacency matrix, which is not affected by any of the changes to the graph layout. For visualization purposes, we manually extended the length of the megakaryocytic, basophilic and monocytic branches by pinning the position of cells at the end of each branch, and allowing the remaining structure to follow. In the bBM sample, we compressed the CEP 'bulge' region of the graph by bringing its bounding cells together.
Smoothing over the kNN graph. We smoothed data over the kNN graph for gene expression visualization and for one analysis (see 'Global changes in gene expression in stress conditions').
Smoothing was done by diffusing the property of interest (for example, gene expression counts or number of mapped cells) over the graph, as described 59 . In brief, let A be the adjacency matrix of the kNN graph, in which A i,j = 1 if an edge in the graph connects nodes i and j. Define A * as the transition matrix, obtained by row-normalizing A:
Let E i be the quantity of interest (for example, expression level) in cell i. Then E * , the smoothed vector of E, is computed as follows:
in which γ is a diffusion constant (γ = 0.05 in all presented analyses) and I is the identity matrix. Formal measure of the continuity of transcriptional states. To demonstrate that the continuous appearance of the Kit + transcriptomes was not a trivial outcome of our analysis methods, we used the same tools to analyse an scRNA-seq dataset of mature blood cells (peripheral blood mononuclear cells, PBMCs) (https:// support.10xgenomics.com/single-cell-gene-expression/datasets/2.0.1/pbmc8k), which consist of several distinct cell types (Extended Data Fig. 1a ). In addition to generating a SPRING plot of the data, we also assessed the interconnectivity of each dataset by examining the behaviour of random walks over the kNN graphs, as previously described 16 . In detail, after subsampling the PBMC data to contain the same number of cells as the bBM dataset, we applied PCA and constructed a kNN graph (k = 10) for each dataset. We then simulated 1,000 random walks for each graph and plotted the fraction of nodes (cells) visited as a function of the number of steps (Extended Data Fig. 1a ). PBA. The PBA algorithm calculates a scalar 'potential' for each cell that is analogous to a distance, or pseudotime, from an undifferentiated source, and a vector of fate probabilities that indicate the distance to fate branch points. These fate probabilities and temporal ordering were computed using the Python implementation of PBA (available online from https://github.com/AllonKleinLab/ PBA), as described 33 . The inputs to the PBA scripts are a set of comma-separated value (.csv) files encoding: the edge list of a kNN graph of the cell transcriptomes (A.csv); a vector assigning a net source/sink rate to each graph node (R.csv); and a lineagespecific binary matrix identifying the subset of graph nodes that reside at the tips of branches (S.csv). These files are provided in the Supplementary Data for the bBM and FL datasets. PBA is then run according to the following steps:
(1) Apply the script 'compute_Linv.py -e A.csv' , here inputting edges (flag '-e') from the SPRING kNN graph (see above). This step outputs the random-walk graph Laplacian, Linv.npy.
(2) Apply the script 'compute_potential.py -L Linv.npy -R R.csv' , here inputting the inverse graph Laplacian (flag '-L') computed in step (1) and the net source/sink rate to each graph node (flag '-R'). This step yields a potential vector (V.npy) that is used for temporal ordering (cells ordered from high to low potential). The vector R provided in the Supplementary Data was estimated as described in the next section.
(3) Apply the script 'compute_fate_probabilities.py -S S.csv -V V.npy -e A.csv -D 1' , here inputting the lineage-specific exit rate matrix (flag '-S'), the potential (flag '-V') computed in step (2), the same edges (flag '-e') used in step (1) and a diffusion constant (flat '-D') of 1. This step yields fate probabilities for each cell.
Figures 1-6 make use of PBA analyses of bBM data. For Fig. 4e and Extended Data Fig. 8 , a temporal ordering of erythroid differentiation was generated for the FL dataset using the same steps, with input files that are also provided in Supplementary Data. Estimation of net source/sink rate vector R. A complete definition of the vector R in terms of biophysical quantities has been published previously 33 . In brief, for a gene expression space described by a vector x = (x 1 , x 2 ,…, x N ) giving the expression of each of N genes, R(x) gives the net imbalance between cell division and cell loss locally for cells with gene expression profile x. R(x) is corrected for cell enrichment and loss resulting from experimental procedures such as sample enrichment, as follows. In this experiment, all progenitors including HSCs express Kit, but eventually downregulate it as they terminally differentiate. Thus, no cells enter the experimental system other than through proliferation of existing Kit + HPCs, but the selection for Kit + cells during sample isolation induces a net sink on cells downregulating Kit expression. For a self-renewing system, cell division and cell loss are precisely balanced, so ∫ = R x x d ( ) 0. To apply PBA, one does not need to estimate R(x), but only its value at points x i at which the M cells i = 1,…, M are observed in the scRNA-seq measurement. Thus R is a vector over the cells in the system. For a self-renewing system, the sum over all cells satisfies the same constraint, ∑ = R 0 i i . Estimation of R. We assigned negative values to R for the ten cells with the highest expression of marker genes for each of the seven terminal lineages (see Supplementary Table 1 for marker genes), which were separately confirmed to show reduced Kit expression. We assigned different exit rates to each of the seven lineages using a fitting procedure that ensured that cells identified as putative HSCs would have a uniform probability to become each fate. Putative HSCs were identified by the similarity of their transcriptomes to microarray profiles from the ImmGen database (we used SC.LT34F.BM (long-term bone marrow HSCs) for bBM and SC.STSL.FL (short-term FL HSCs) for FL; for more details, see section 'ImmGen Bayesian classifier'). We assigned a single positive value to all remaining cells, with the value chosen to enforce the steady-state condition ∑ = R 0 i i . In the fitting procedure, all exit rates are initially set to one and iteratively incremented or decremented until the average fate probabilities of the putative HSCs were within 1% of uniform. The resulting vector R is provided in the Supplementary Data. The separate lineage exit rates were then used to form the lineage-specific exit rate matrix S, also provided in the Supplementary Data. Assignment of PBA fate probabilities and temporal ordering to eBM dataset. For each of the eBM cells we assigned the average temporal order (or potential V) and average fate probabilities of the 20 mostly similar bBM cells. To do this, we first carried out a PCA on the bBM cells into 60 dimensions. We then used the gene loadings of the 60 principal components to project the eBM data into the same principal component space. The distance of each eBM cell to each bBM neighbour was then measured by cosine distance in the 60-dimensional sub-space. ImmGen Bayesian classifier. We used a published microarray profile 60 to search for similar cells in our own dataset using a naive Bayesian classifier, implemented as follows.
The Bayesian classifier assigns cells to microarray profiles on the basis of the likelihood of each microarray profile for each cell, with the likelihood calculated by assuming that individual mRNA molecules in each cell are multinomially sampled with the probability of each gene proportional to the microarray expression value for that gene. Consider a matrix E of mRNA counts (UMIs) with n rows (for cells) and g columns (for genes), and also a matrix M with m rows (for microarray profiles) and g columns (for genes). M was quantile normalized and then each microarray profile was normalized to sum to one. Normalization of E was performed as described earlier (see 'Cell filtering and data normalization'). The n × m matrix, S ij , giving the likelihood of each microarray profile j for each cell i is,
where Z i is a normalization constant that ensures that ∑ = S 1 i ij . Computing the haematopoietic lineage tree. We used the fate probabilities from PBA to infer the topology of the haematopoietic lineage tree using an iterative approach (Fig. 1e, f) . Each iteration began with a set of fates and a probability distribution over those fates for each cell. For every pair of fates, we computed a fate coupling score (see later) and merged pairs with a score significantly higher than expected under a null model. The merged fates inherited probabilities from the starting fates by simple pairwise addition.
The coupling score between two fates A and B is the number of cells with P(A)P(B) > ε, in which we used a value ε = 1/14 throughout. To generate a null distribution for each fate pair, we computed pairwise coupling scores for 1,000 permutations of the original fate probabilities. The heat maps in Fig. 1e show z-scores with respect to these null distributions. Analysis of fate-correlated genes at haematopoietic choice points. To discover fate-associated genes at key choice points in haematopoiesis (Extended Data Fig. 2, Supplementary Table 2 ), we ranked transcription factors and cell-surface markers (transcription factors from http://genome.gsc.riken.jp/TFdb/tf_list. html, cell-surface markers from https://www.thermofisher.com/us/en/home/lifescience/cell-analysis/cell-analysis-learning-center/cell-analysis-resource-library/ ebioscience-resources/mouse-cd-other-cellular-antigen.html) by their correlation with PBA-predicted fate probability, restricting to cells that were bipotent for the given choice. Specifically, to find transcription factors associated with fate A at an A/B choice point, we first selected cells with P(A) × P(B) > ε, and then ranked the transcription factors by their correlation with the fate bias (P(A) − P(B) ). In Supplementary Table 2 , we report all genes with Bonferroni-corrected P < 0.01 (Pearson correlation coefficient). In Extended Data Fig. 2 , we show at most ten genes for any one choice point. Mapping P1-P5 subsets to the Kit + graphs. For Fig. 2b , cells from subsets P1-P5 were projected into the same principal component space as the bBM data, then mapped to their most similar Kit + neighbours. In detail, counts were first converted to TPM for all samples. Then, using only the bBM cells, the 3,000 most variable genes (measured by v-score) with at least three UMIFM in at least three cells were z-score normalized and used to find the top 50 principal components. Next, the P1-P5 subset cells were z-score normalized using the gene expression means and s.d. from the bBM data and transformed into the bBM principal component space. Lastly, each P1-P5 cell was mapped to its closest bBM neighbour in principal component space (Euclidean distance). Extracting MPP-to-erythroid trajectory cells. To isolate the erythroid trajectory, we defined an MPP-to-erythroid axis in each of the three Kit + datasets by ordering cells on the basis of their graph distance from unbiased MPPs (cells identified on the basis of the ImmGen classifier as described earlier), and keeping only cells for which the probability of erythroid fate increased or remained constant with graph distance. Graph distance was measured by PBA potential, and starting with the cell closest to the HSC origin, we added the cell with next highest potential to the trajectory if the PBA-predicted erythroid probability for cell i was at least 95% of the average erythroid probability of the cell(s) already in the trajectory.
More formally the procedure is as follows: order all N cells in the experiment from highest to lowest PBA potential V, with decreasing potential corresponding to increasing distance from MPPs 33 . Let E i be an indicator variable for the membership of ordered cell i in the erythroid trajectory (E i = 1 if cell i is in the trajectory; otherwise, E i = 0). If P i is the PBA-predicted erythroid probability for ordered cell i,
Cells on the erythroid trajectory were then ordered by decreasing potential. Defining t j as the index of the jth erythroid-trajectory cell,
Throughout this Article, we report this cell order (akin to the 'pseudotime' in other publications) as a percentage of ordered cells, with the first, least differentiated cell at 0% and the most mature cell at 100%. This is not meant to suggest that erythroid differentiation ends with this final observed cell. Identifying dynamically varying genes. For each gene, a sliding window (n = 100 cells) across the MPP-to-erythroid ordering was used to identify the windows with maximum and minimum average expression as previously described 57 . A t-test was then performed to assess the statistical significance of the difference in expression levels. To estimate the false discovery rate (FDR), we permuted the order of the cells and repeated the above analysis 57 . For a P value generated by the observed (non-permuted) ordering, the FDR-corrected P value is the fraction of genes from the permuted ordering with that P value or less. Any gene with an FDR-corrected P < 0.05 was considered significantly variable. Identifying stage transitions in the MPP-to-erythroid trajectory. Transition points between stages of erythropoiesis were defined using the frequency of gene inflection points (Fig. 4b) , patterns of PBA-predicted fate probabilities (Fig. 1c) , and the fate potentials of FACS subsets P1-P5 (Figs 2, 3) . However, owing to the continuous nature of the transcriptional states, the locations of these transitions should be considered approximate.
The inflection point density is the number of genes turning on or off at a given point on the trajectory. For each gene, inflection points were identified as the points with maximally increasing or decreasing expression as follows. First, the trajectory of each dynamically varying gene was smoothed using Gaussian smoothing with a width σ = 5% of total trajectory. The gene expression derivative for gene k, denoted x k , was then computed by taking a ten-cell moving average of the difference between consecutive smoothed gene expression values. Inflection points were then identified as the points with maximum or minimum derivatives for each gene. To exclude maxima or minima resulting from relatively small fluctuations in gene expression, only appreciably large extrema were kept for further analysis. Specifically, the point with the maximum derivative for gene k, max(x k ), was kept only if
Minima were similarly filtered, requiring the ratio to be <−Q. We chose a threshold Q = 6, but results do not qualitatively change over a range of Q. We then plotted the density of these inflection points over the MPP-to-erythroid axis. Regions with large-scale changes in gene expression have a high density of inflection points, whereas a low density characterizes relatively stable states. Dynamic gene clustering. Dynamically varying genes were clustered on the basis of their behaviour at the transition points. To prevent overfitting, we used only three transitions (3%, 18% and 86%) by splitting the EEP state and assigning the first and second halves to the EBMP and CEP states, respectively. At each transition, genes were classified as increasing, decreasing or unchanging, giving a total of 3 3 = 27 possible patterns. After smoothing gene expression traces, the data were binned by calculating the mean expression in each of the four stages. To remove noisy genes or genes that varied little across bins, we calculated the range of binned expression values, range(x i,binned ) = max(x i,binned ) -min(x i,binned ), for each gene and proceeded with the top 50% most variable genes. Next, to place all genes on a similar scale, the binned expression values of each gene were divided by the maximum binned value of that gene. Finally, the differences between consecutive bins were thresholded: differences that were greater than 0.15 were called increasing, differences that were less than −0.15 were called decreasing and differences that were between −0.15 and 0.15 were called unchanging. Gene set enrichment analysis. Each of the 27 gene clusters was used as input for gene set enrichment analysis (GSEA) (hypergeometric test), using all genes as background. Ribosomal genes were excluded from the input, as were predicted genes (gene names starting with 'Gm'). Gene sets from the following lists of the MSigDB v5.1 (ref. 61) dataset were tested for enrichment: Hallmark (h.all.v5.1.symbols. gmt), C2 curated canonical pathways (c2.cp.v5.1.symbols.gmt), C3 transcription factor targets (c3.tft.v5.1.symbols.gmt), and C5 Gene Ontology (c5.all.v5.1.symbols.gmt). Additionally, for the transcription factor target enrichment analysis, we used gene sets from the ChEA database 62 . Cell cycle phase analysis. Genes with periodic expression correlated with the cell cycle in HeLa cells 52 were used to generate a cell cycle phase score for each cell. The list of phase-specific genes was filtered to exclude genes with a mean expression > 25 TPM in cells on the MPP-to-erythroid trajectory. For Fig. 6a , a sliding window average was computed using a window size of 10% MPP-toerythroid progression (~200 cells) and a jump size of 5%. For Fig. 6b , counts were normalized by the mean expression at the gene level, and smoothed using a Gaussian kernel. Then, a phase score was calculated for each phase (G1/S, S, G2/M, M, M/G1) by averaging the smoothed gene expression traces for the genes specific to that phase. Testing the influence of cell cycle genes on the MPP-to-erythroid cell order. To test the extent to which cell cycle genes influenced the ordering of cells along the MPP-to-erythroid trajectory, we excluded annotated cell cycle genes as described 63 (cell cycle genes were extracted from the Gene Ontology database (GO:0007049) and Cyclebase 64 ), and repeated kNN graph construction and PBA. As shown in Extended Data Fig. 10 , the resulting cell order was largely unchanged, as were the dynamics of cell cycle genes. Identifying genes that change steadily in the CEP stage. To identify genes that are steadily up-or downregulated throughout the CEP (Fig. 6c , Supplementary  Table 6 ), we tested the magnitude of change (slope) and the linearity of change (the error of the actual gene trace from a straight line) for each gene. Restricting analysis to cells in the CEP stage and genes with at least two UMIFM in at least five cells, we fit a linear regression to the ordered gene expression values and also generated a smoothed expression trace using a Gaussian kernel (width σ = 5%). We then computed a 'linearity score' for each gene by dividing the slope of the regression line by the root-mean-square error between the regression line and the smoothed trace. Steadily increasing genes receive large positive scores, whereas Article reSeArcH steadily decreasing genes are assigned large negative scores. Genes that do not change much or that change nonlinearly (for example, sharply increasing only at the end of the stage) receive scores close to 0. Global changes in gene expression in stress conditions. Cells from eBM and FL (stress samples) were mapped to their most similar bBM counterparts, and differentially expressed genes were identified. Mapping was carried out by applying PCA to the bBM and stress samples and finding the closest 20 bBM neighbours for each stress cell. Specifically, the input genes were the principal variable genes described in the 'Cell filtering and data normalization' section. Count matrices were z-score normalized separately for each sample, and PCA was performed on the basal sample to obtain the gene loadings. Using the top 60 principal components, each sample was then transformed using these coefficients, thereby projecting the cells into the same PCA space. To validate this mapping method, we performed the same procedure using different subsets of bBM data as training and test sets (see 'Validation of cross-sample cell mapping' section)
The 20 closest bBM neighbours (Euclidean distance) of each stress cell were found, and for the purpose of comparing gene expression, each of these k (20) neighbours inherited 1/k (1/20) of the transcript counts from the mapped stress cell. To enable the comparison of regions of gene expression space (as opposed to comparing single mapped cells to single basal cells), the mapped and original gene expression values were smoothed over the kNN graph, as described in 'Smoothing over the kNN graph' . To avoid comparing gene expression patterns in regions that were relatively unpopulated in the stress sample (for example, parts of the granulocyte branch), we smoothed the number of mapped stress cells per basal cell over the graph and then excluded basal cells with few mapped stress cells (number mapped cells ≤ 9 for eBM and ≤ 20 for FL).
A differential expression score for each cell i and gene j was defined as the maximum-normalized difference between mapped and basal expression, ⁎ x i j , and x i j , , respectively:
A gene level score, D j , was created by summing over the cells, = ∑ D d
in which D is the average over all gene level scores D j and σ D is the standard deviation. Then, for each differentially expressed gene, the gene was counted as differentially expressed at a given cell if d i,j > 0.5 × δ high or d i,j < 0.5 × δ low , in which δ high is the 99th percentile of D j and δ low is the 1st percentile of D j .
Validation of cross-sample cell mapping.
To test the accuracy of the method for mapping eBM and FL cells to bBM cells, we divided the bBM sample into a training set (random sample of 75% of the cells) and test set (the remaining 25%). The mapping procedure described in the previous section was then used to map the test set to the training set. As one measure of the accuracy of the mapping, we assigned the test cells the average PBA-predicted fate probabilities and differentiation ordering of the training cells to which they mapped. Both measures were relatively unchanged from their original values (Spearman correlation of 0.97 for the differentiation ordering and >0.95 for each fate probability). As a second measure, we repeated the test for finding global changes in gene expression, using the same gene level score (D j ) cut off as for the eBM sample. This revealed no significantly differentially expressed genes between the training and test sets. Region-specific differential expression. Before identifying differentially expressed genes, we excluded genes with large batch effects. Although different sequencing depths led to a small change in the average expression of many genes from the first batch to the second, a small number of genes showed major batch effects beyond this, presumably owing to differences in library preparation. We performed a binomial test for differential expression 65 between the two batches of cells and excluded genes with P < 10 −50 , resulting in the removal of 461 genes.
In general, genes can be differentially expressed globally or only in specific cell populations. Particularly when comparing FL to bBM samples, many genes showed global up-or downregulation. To identify differentially expressed genes that are likely to be important specifically for erythropoiesis (or in a particular stage of erythropoiesis), we created a region-specific differential expression score. This score measures the magnitude of the expression difference within a region of interest (ROI) relative to the magnitude outside the region; genes with a larger difference within the ROI than outside of it receive a high score (positive for upregulation, negative for downregulation). For the analyses described here, we tested for differential expression in five ROIs: the stages of the erythroid trajectory, EBMP, EEP, CEP, and ETD and an expanded selection of MPP cells, which included cells with a maximum PBA-predicted lineage probability (for all lineages) less than 0.4, with the exception of cells already included in one of the stages of the erythroid trajectory.
After mapping stress cells to their single closest neighbour in the bBM sample (as described in the previous section), we selected bBM cells in the ROI and the stress cells mapping to them. We first identified genes differentially expressed within the ROI by performing a binomial test for differential expression 65 , which tests the probability that a gene is expressed more frequently in one population than another. After correcting for multiple hypothesis testing (Benjamini-Hochberg procedure 66 ), we proceeded with genes with an FDR-corrected P < 0.05.
To identify genes differentially expressed specifically within the ROI and not elsewhere, we calculated the mean-normalized expression difference for ROI cells and non-ROI cells for the genes found to be significant in the binomial test. For two samples, A (stress) and B (basal), the mean-normalized expression difference of gene i within the ROI, y in,i , is
in which x i A in, is the average expression of gene i within the ROI in sample A. A simi lar score was calculated for cells outside the ROI:
Plotting y in,i against y out,i clearly reveals genes that are more highly differentially expressed within the ROI than without. A single score per gene was computed as follows:
Intuitively, this score is large and positive if a gene is more strongly upregulated within the ROI than without, large and negative if a gene is more strongly downregulated within the ROI than without and close to 0 otherwise. To build gene lists for GSEA input, we first selected genes with score i > 0.1 × max(score) (for upregulated genes) or score i < 0.1 × max(score) (for downregulated genes) and then used the top 100 genes by binomial test P value. Flow cytometric sorting for P1-P5 subsets. A detailed protocol of this procedure can be found at the Protocol Exchange 67 .
Bone marrow cells from adult BALB/cJ male or female mice (aged 8-12 weeks) were lineage-depleted using the Mouse Streptavidin RapidSpheres Isolation Kit (STEMCELL Technologies 19860A), with the following biotinylated antibodies: anti-CD11B (clone M1/70, BD Biosciences 557395), anti-LY-6G and LY-6C (clone RB6-8C5, BD Biosciences 553125), anti-CD4 (clone RM4-5, BD Biosciences 553045), anti-CD8A (Ly-2) (clone 53-6.7, BD Bioscience 553029), anti-CD19 (clone 1D3, BD Biosciences 553784), anti-TER119 (clone TER119, BD Biosciences 553672).
Lineage-depleted cells were then labelled with the following antibodies in the presence of 1% rat serum: streptavidin Alexa Fluor 488 (Molecular Probes) to mark lineage-positive cells, CD117-APC Cy7 (clone 2B8, Biolegend 105826), TER119-BUV395 (clone TER-119, BD Biosciences 563827), CD71-PE Cy7 (clone RI7217, Biolegend 113812), CD55-AF647 (clone RIKO-3, Biolegend 131806), CD105-PE (clone MJ7/18, Biolegend 120408), CD150-BV650 (clone TC15-12F12.2, Biolegend 115931), CD41-BV605 (clone MWReg30, Biolegend 133921), CD49f (also known as ITGA6)-BV421 (clone GoH3, Biolegend 313624) After washes, cells were re-suspended in DAPI-containing buffer and sorting was performed using a BD FACSAria II with a 100-μm nozzle. Sorted populations were defined as in Fig. 2a . qRT-PCR on sorted populations. RNA was prepared from sorted cell subsets using the RNeasy Micro Kit (Qiagen 74004) or TRIzol reagent (Ambion 15596026), and measured with RiboGreen RNA reagent kit (Thermo Fisher Scientific) on the 3300 NanoDrop Fluorospectrometer. cDNA was synthesized using the same amount of input RNA for all samples in a parallel reaction, using the Super Script III first-strand synthesis system for RT-PCR (Invitrogen) with random hexamer primers. The ABI 7300 sequence detection system, TaqMan reagents and TaqMan MGB probes (Applied Biosystems) were used following the manufacturer's instructions. Quantitative PCR was carried on four serial dilutions of each cDNA sample, and the linear part of the template dilution/signal response curve was used to calculate relative mRNA concentrations following normalization to Actβ, using the ΔC t method.
The following TaqMan MGB probes were used:
Fresh growth factors were added to the medium of each well on days 4 and 8. The clones in each well were labelled on days 3, 7 or 10, with the same antibody cocktail as described in the 'Bulk liquid cultures of sorted cell populations' section, but with concentrations for each antibody batch that were first optimized with appropriate titrations, to minimize non-specific binding under conditions of low cell number. Clones were analysed using the high throughput sampler (HTS) attachment of the BD LSR II (BD Biosciences). Fate co-occurrence from single-cell liquid culture data. To measure the statistical significance of fate co-occurrence from the single-cell fate assay data, we used a method similar to that described for calculating fate couplings from the PBA predictions (see 'Computing the haematopoietic lineage tree' section). Because we assayed clonal fate from each FACS subset separately, clones were not represented at the same frequency as in the Kit + pool (number of clones assayed: CD55 − , n = 58; P1, n = 287; P2, n = 324; P3, n = 125; P4, n = 96; P5, n = 268; average frequency in Kit + population: CD55 − 59.1%, P1 21.4%, P2 6.6%, P3 4.0%, P4 0.8%, P5 4.9%). To adjust for this, we randomly resampled the clone data to ensure clones from each subset were represented in the same proportion as in the Kit + population (originally: n = 1,158 clones; after resampling: n = 8,000 clones). We then computed the observed fate co-occurrence for each fate pair as the number of clones with >2% of cells of the two fates (permitting the presence of other fates as well). Next, we estimated the null distribution by shuffling the data of each fate separately (2,000 replicates) and counting fate co-occurrence as described earlier. Lastly, we calculated the significance of the co-occurrence of each fate pair as the z-score of the observed co-occurrence with respect to the null distribution.
In Fig. 3d , the expectation value (E) and s.e.m. for the fraction of bipotent erythroid-basophil cells from each independent experiment were calculated from a β posterior distribution, that is, E(p) = (n + 1)/(N + 2) and , in which p is the fraction of bipotent cells, n is the observed number of bipotent cells, and N is the total number of cells assayed. Growth factor perturbations of erythroid colony formation. CFU-e and BFU-e colony-formation assays in MethoCult (STEMCELL Technologies M3234) were carried out on either freshly isolated adult bone marrow or on fetal liver cells extracted at embryonic day 13.5 from BALB/cJ mice. The following growth factors were tested: MSP/MST1 (R&D Systems 6244-MS-025), recombinant human/ mouse WNT5A (R&D Systems 645-WN-010) and recombinant murine IL-17A (PeproTech 210-17). In each experiment, a range of EPO concentrations was tested, with or without additional growth factors (MSP, WNT5A or IL-17A) as indicated in Fig. 5 and Extended Data Fig. 9 . In the BFU-e assays, IL-3 (10 ng ml −1 ) and SCF (50 ng ml −1 ) were added to the MethoCult in addition to EPO. Each condition was tested in quadruplicate in at least two separate experiments. Colonies were scored on day 3 (for CFU-e), day 4 (for late BFU-e) and day 7 (for early BFU-e) following staining with diaminobenzidine, to highlight haemoglobin expression. Il17ra −/− mice. 
Cell cycle studies. Flow cytometric cell cycle analysis of bone marrow cells in vivo.
Flow cytometric analyses were carried out as described 47 . In brief, BrdU (100 μl of 10 mg ml −1 stock in PBS) was injected intraperitoneally into adult mice 30 min before euthanasia. After collection of bone marrow, cells were immediately placed in cold staining buffer, labelled using a LIVE/DEAD kit (Invitrogen) to identify dead cells and were then fixed and permeabilized. Cell-surface staining for each of the five subsets P1-P5 was carried out as described earlier. Simultaneously, incorporated BrdU was detected using a biotin-conjugated anti-BrdU antibody (Abcam) following mild digestion with DNaseI. DNA content was assayed by labelling with the fluorescent indicator 7-AAD (BD Biosciences). Cells were then analysed for cell-surface labelling, BrdU incorporation and DNA content by flow cytometry. Cell cycle arrest studies during erythroid differentiation in vitro. Bone marrow cells were collected and immediately enriched for Kit + Lin − TER119 − CD71 − cells using magnetic beads, as described earlier. The enriched cell fraction was initially placed in culture in IMDM with 20% FCS and EPO (2 U ml −1 ), in the presence or absence of aphidicolin (6 μM, Sigma A0781). After 10 h, all the cells were washed three times in culture medium to remove aphidicolin, and returned to culture, which continued for up to a total of 36 h. At the indicated time points, cell aliquots were taken for RNA extraction followed by qRT-PCR of Hbb-b1 and Actb and for a simultaneous flow cytometric analysis of CD71, TER119 expression and cell cycle status. For the latter, cells were pulsed with BrdU (33 μM) in vitro for 25 min before collection, then processed as described earlier for BrdU incorporation, DNA content and cell-surface CD71 and TER119 expression. Western blot analysis. Bone marrow cells were sorted as described earlier, except that the P1 population was further subdivided into CD71 medium and CD71 high subsets. For negative controls, we used 3T3-L1 cells. For positive controls, 3T3-L1 cells were transduced with the MICD4-GATA1 retrovirus as described 47 . Cell pellets were snap-frozen in liquid nitrogen after sorting.
Cell lysates were quantified using the BCA Protein Assay Kit (Pierce) and sepa rated by SDS-PAGE. PVDF membranes were probed with antibodies against GATA1 (N6, Santa Cruz sc-265), β-actin (Abcam ab8227), MCM5 (Bethyl Laboratories A300-195A-M), MCM6 (Bethyl Laboratories A300-194A), MCM2 (Bethyl Laboratories A300-191A), PCNA (PC10) (Santa Cruz sc-56) and IL-17RA (R&D Systems AF448).
Western blot membranes were quantified using the BIORAD Imaging system and Image Laboratory software. Intracellular signalling by STAT3 and STAT5. Freshly collected bone marrow cells were enriched for Lin − TER119 − cells using magnetic beads, as described above. The enriched cells were incubated in cytokine-free, low-serum medium (IMDM with 2% FCS) for 3 h. EPO (0.5 U ml −1 ), IL-17A (20 ng ml −1 ) or both together was then added to the medium for either 30 or 60 min. Cells were collected, washed with PhosphoWash Buffer 69 , stained with a LIVE/DEAD kit (Invitrogen), fixed and permeabilized with Cytofix/Cytoperm Buffer (BD Biosciences 554722) supplemented with 1 mM sodium orthovanadate (Sigma 450243-10G), 1 mM β-glycerophosphate (Sigma G9422-10G) and 1 μg ml −1 Microcystin (EMD Millipore 475815-500UG), and Perm/Wash Buffer I Extended Data Figure 6 | Gene set enrichment on dynamic gene clusters in early erythroid differentiation. a-d, Nine key dynamic gene clusters along the MPP-to-erythroid progression (Extended Data Fig. 5e ) are analysed further for Gene Ontology terms. Each cluster is identified by its dynamic pattern with a cartoon of nodes and edges. Each node represents a progenitor stage (in order, MPP, EBMP/EEP, CEP and ETD), connected to the next stage by an edge that either goes up (for increased expression) or down (for decreased expression) (see Extended Data Fig. 5e ). a, Number and identity of transcription factors (TFs) whose targets are enriched in the dynamic clusters, as predicted by chromatin immunoprecipitation methods (ChIP-X) experiments 62 . b, Significance of enrichment for signalling pathways and Gene Ontology gene sets in the dynamic gene clusters (hypergeometric test with Benjamini-Hochberg correction for multiple hypothesis testing). Rep., representative. c, d, Enrichment of transcription factor targets. c, Heat map (−log 10 of P value of hypergeometric test with Benjamini-Hochberg correction for multiple hypothesis testing) of target gene enrichment for transcription factors (rows) with targets significantly enriched (P < 0.05) in at least one of the nine dynamic clusters (columns, labelled on top) highlighted in Extended Data Fig. 5e . Note that the transcription factor targets shown are based on previous ChIP-X experiments 62 and it is possible that unappreciated transcription factor targets occur in early erythropoiesis. d, Gene expression traces over the erythroid trajectory for the transcription factors from c. Rows match those in c. Corresponding author(s): Klein/ Socolovsky
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Experimental design 1. Sample size
Describe how sample size was determined. All relevant sample sizes are described in the legend to each figure and/or in the materials and methods section. Sample sizes were determined based on previous experience with each of the experimental systems. Statistical tests were not used to pre-determine sample size.
Data exclusions
Describe any data exclusions. Data exclusions are described in detail in the materials and methods section.
In the case of scRNA-seq data, contaminating cell types and putative cell doublets were excluded from analysis based on criteria that are describe in detail in the method section "Exclusion of contaminating cell types and putative cell doublets".
No data was excluded from mouse or cell biology experiments, with the exception of very occasional technical failure in the experimental procedure such as machine failure during a sorting experiment.
Replication
Describe whether the experimental findings were reliably reproduced.
At least two independent experiments were performed for the results in the manuscript, except for inDrops experiments, which were performed on a single basal bone marrow sample pooled from the bone marrow of 10 mice, or on a single Epo-stimulated bone -marrow sample from pooled from the bone marrow of 10 mice; or from a single fetal liver sample pooled from the fetal livers of 10 embryos. Each of the inDrops samples included several thousand cells as indicated in each corresponding figure. All reported data were reproduced reliably.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Experiments entailed manipulating very similar primary cell samples, derived from inbred mice of similar age, sex and weight, making randomization not applicable.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not used. Readouts were quantitative and not subject to subjective judgment of investigators.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
-FACS data was analyzed using the FlowJo 9.9.5 software.
-Western blots were analyzed using the Biorad Image Lab Software 6.0 -Data analysis and graphics: GraphPad Prism 7.0a, Excel version 15.32 -Python (version 2.7), using scripts described in methods section and code available at: -https://github.com/indrops/indrops -https://github.com/AllonKleinLab/SPRING -https://github.com/AllonKleinLab/PBA For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
there are no restrictions on material availability.
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Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Mice
For scRNA-seq studies: the basal state bone marrow sample (bBM), and for the sorted populations P1 to P5, bone marrow was harvested from 8-week old adult BALB/cJ female mice (Jackson Laboratories, Maine, USA). For the Epo-stimulated adult bone-marrow sample (eBM), 8-week old adult Balb/cJ female mice were injected with Epo (Procrit, Amgen corporation) sub-cutaneously once per 24 hours for a total of 48 hours, at 100 Units/25 g. For the fetal liver sample (FL), BALB/cJ female mice were set up for timed pregnancies, and fetal livers were harvested on embryonic day 13.5.
For other experiments: BALB/cJ male or female mice, ages 8 to 12 weeks were used.
For colony formation assays using IL-17RA-deleted mice: 
} Data presentation
For all flow cytometry data, confirm that:
